Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Killugudi, Jayaraman"'
Autor:
Killugudi Jayaraman
Publikováno v:
Nature Biotechnology. 37:1388-1389
Indian startups plan affordable CAR-T therapies—first for domestic use, then for the global market.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::11c62c747697529b01f4286588fe7789
https://doi.org/10.1038/s41587-019-0346-1
https://doi.org/10.1038/s41587-019-0346-1
Autor:
Killugudi Jayaraman
Publikováno v:
Nature. 575(7783)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b02561bfbcace236448dfcb26a928a12
https://pubmed.ncbi.nlm.nih.gov/31745362
https://pubmed.ncbi.nlm.nih.gov/31745362
Autor:
Killugudi Jayaraman
Publikováno v:
Nature biotechnology. 36(5)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b2c036e37699af8282e78454f7c272d
https://pubmed.ncbi.nlm.nih.gov/29734304
https://pubmed.ncbi.nlm.nih.gov/29734304
Autor:
Killugudi Jayaraman
Publikováno v:
Nature medicine. 24(2)
A shot at contraception: In India, a nonagenarian renews testing of a birth control vaccine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::339f38cce83b45d9203d7b512774b7e4
https://pubmed.ncbi.nlm.nih.gov/29414934
https://pubmed.ncbi.nlm.nih.gov/29414934
Autor:
Killugudi Jayaraman
Publikováno v:
Nature Medicine. 20:802-805
Two years ago, Gyanendra Nath Singh was tasked with overseeing India's drug regulatory agency. Despite the US having temporarily suspended a suite of trials in India and banned drug imports from several manufacturers there over the last couple of yea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3f4733ae9b97f77ffb388f8b73887b5b
https://doi.org/10.1038/nm0814-802
https://doi.org/10.1038/nm0814-802
Autor:
Killugudi Jayaraman
Publikováno v:
Nature Medicine. 19:1200-1203
Discovering the right compound that can treat an infection such as HIV is only the first piece of the drug development puzzle. The next challenge is to make the manufacturing process more efficient—and thereby cheaper. Killugudi Jayaraman meets wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::53f8b869b7d28c4a703936d8dd5161de
https://doi.org/10.1038/nm1013-1200
https://doi.org/10.1038/nm1013-1200
Autor:
Killugudi Jayaraman
Publikováno v:
Nature Biotechnology. 35:1124-1124
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::594e4fc05659a87c2e5735286a99db3a
https://doi.org/10.1038/nbt1217-1124a
https://doi.org/10.1038/nbt1217-1124a
Autor:
Killugudi Jayaraman
Publikováno v:
Nature Biotechnology. 35:698-698
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4a698c48df1849b2063d09f0823afe8
https://doi.org/10.1038/nbt0817-698
https://doi.org/10.1038/nbt0817-698
Autor:
Killugudi Jayaraman
Publikováno v:
Nature Biotechnology. 34:367-367
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1cce1d027a5ecd5fab06ce5750da8268
https://doi.org/10.1038/nbt0416-367
https://doi.org/10.1038/nbt0416-367
Autor:
Killugudi Jayaraman
Publikováno v:
Nature medicine. 16(4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69eb4d83acc142be7072913d4c7b581a
https://pubmed.ncbi.nlm.nih.gov/20376034
https://pubmed.ncbi.nlm.nih.gov/20376034